Mandadi Tilak bought CVS
April 1, 2024 · Form 4 insider transaction
Mandadi Tilak bought 16,339 shares of CVS Health Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,339
Price
$0.00
Total value
N/A
InsiderMandadi Tilak
Role—
CompanyCVS Health Corporation (CVS)
SecurityCommon Stock (RSU)
Transaction codeA: Grant or award
Transaction dateApril 1, 2024
Filing dateApril 3, 2024
Shares owned after82,904
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025.